Hostname: page-component-848d4c4894-wzw2p Total loading time: 0 Render date: 2024-06-09T09:27:55.401Z Has data issue: false hasContentIssue false
  • English
  • Français

A comparison of symptoms following treatment interruption: Evidence from a randomized, double-blind trial with fluoxetine, sertraline, and paroxetine

Published online by Cambridge University Press:  16 April 2020

M. Fava ,
J. Rosenbaum ,
S. Hoog ,
W. Krebs  and
J. Dillon
M. Fava
Affiliation:
The Fluoxetine Collaborative Study Group: 1Massachusetts General Hospital, Boston, Massachusetts02114
J. Rosenbaum
Affiliation:
The Fluoxetine Collaborative Study Group: 1Massachusetts General Hospital, Boston, Massachusetts02114
S. Hoog
Affiliation:
Eli Lilly and Company, Indianapolis, Indiana46285, USA
W. Krebs
Affiliation:
Eli Lilly and Company, Indianapolis, Indiana46285, USA
J. Dillon
Affiliation:
Eli Lilly and Company, Indianapolis, Indiana46285, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 13 , Issue S4: Standards of psychiatry - 9th Congress of Association of European Psychiatrists , 1998 , pp. 204S - 205S
Copyright
Copyright © European Psychiatric Association 1998
Submit a response

Comments

No Comments have been published for this article.